Health Condition 1: C259- Malignant neoplasm of pancreas, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Between 2000 and 2020, patients who underwent curative-intent (R0 or R1 resection) pancreatectomy for pancreatic cystic neoplasms. -Patients who were histologically diagnosed with MCNs in the final surgical specimen pathology report.
Exclusion criteria
Exclusion criteria: - Patients with other synchronous or metachronous cancer - Patients who received neoadjuvant chemotherapy or radiotherapy - Patients who died within 90-days after surgery because of operative complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the preoperative risk factors for advanced neoplasia in MCNsTimepoint: Before surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the proportion of advanced neoplasia among resected MCNsTimepoint: 15 days after surgery;To evaluate the prognosis of resected MCNs depending on the presence of advanced neoplasiaTimepoint: 15 days after surgery | — |
Countries
Australia, Austria, China, France, Germany, India, Italy, Japan, Netherlands, Republic of Korea, Serbia, Singapore, Taiwan, United States of America
Contacts
TATA MEMORIAL HOSPITAL